She also has a past medical history significant for a hypercoagulable state with femoral thrombus and pulmonary emboli, as well as hypertension, hyperlipidemia, congestive heart failure, cataracts and asthma as stated earlier, intermittent claudication.
She was then referred to Cardiac Surgery for coronary artery bypass grafting.
Lasix 120 mg q.d.
Lipitor 5 mg q.d.
Vitamin D. 4.
Prilosec 20 mg q.p.m.
Covera 480 mg q.h.s.
Lovenox 130 mg. 10.
Captopril 25 mg t.i.d.
Ventolin inhaler.
ALLERGIES:  Beta-blockers, clonidine, Zestril, calcium, channel blockers, terazosin, Cozaar, Cardura, hydrochlorothiazide, aldomet and reserpine.
HOSPITAL COURSE:   She underwent coronary artery bypass grafting times three [**2136-8-27**] with a left internal mammary artery to the diagonal, saphenous vein graft to the obtuse marginal and the saphenous vein graft to the posterior descending artery.
The patient was transferred to the Cardiac Surgery Recovery unit in stable condition on .3 mcg/kg/minute of Neo-Synephrine and Propofol, being AV paced at 88.
The plan was to start her discharge planning, to increase her Lasix, and to monitor her urine output, to continued her Coumadin and to start her heparin.
The plan was to discontinue her Lopressor and to start diltiazem and to continue her current medications for pain control.
Physical examination was benign and the plan was to continue her rehabilitation screening.
Covera hs 480 mg q.h.s.
Lipitor 5 mg po q.d.
Ergocalciferol 400 units t.i.d.
Pantoprazole 40 mg po q.d.
Montelukast 10 mg po q.d.
Lasix 20 mg po q.d.
Ipratropium bromide 2 puffs q.i.d.
Albuterol 2 puffs q.
Coumadin 5 mg q.h.s.
Tylenol #3 1-2 tablets po q.
4 hours prn pain.
Serevent 2 puffs b.i.d.
Potassium Chloride 20 mEq q.d.
Lovenox 130 mg subcutaneous q.
Vitamin D 400 mg t.i.d.
Calcium carbonate 500 mg t.i.d.
DISCHARGE DIAGNOSIS:  Coronary artery disease, status post coronary artery bypass grafting times three.
